КИМ, Таэ-Кёнг (KR),АН, Юнг Чу (KR),У, Чон Вон (KR),ЧХА, Чи-Ын (KR),ЛИ, Чоан Юн Чи (KR),ЧАН, У Ик (KR)
申请号：
RU2018132694
公开号：
RU2018132694A
申请日:
2017.02.16
申请国别(地区):
RU
年份:
2020
代理人:
摘要：
Provided is a method for administering a recombinant human growth hormone GX-H9 for treating growth hormone deficiency. Particularly, the present disclosure relates to a pharmaceutical composition for treating growth hormone deficiency, containing a recombinant hGH GX-H9 and a pharmaceutically acceptable carrier, in which the recombinant GX-H9 is administered once a week with a dosage of 0.1 to 0.3 mg per weight kg of a patient or twice-monthly with a dosage of 0.1 to 0.4 mg per weight kg of the patient. Further, the present disclosure relates to a method for treating growth hormone deficiency including administering an recombant hGH GX-H9 to a patient with growth hormone deficiency once a week with a dosage of 0.1 to 0.3 mg per weight kg of the patient or twice-monthly with a dosage of 0.1 to 0.4 mg per weight kg of the patient.
